Inhibition of excessive phospholipase A.sub.2 activity and/or production by non-antimicrobial tetracyclines
US5523297A · kind A · utility
31Cited by
9References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 21, 1995 |
| Grant date | Jun 4, 1996 |
| Priority date | — |
| Expiry date | Apr 21, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/65
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating mammals suffering from conditions associated with excess phospholipase A.sub.2 activity and/or production comprising administering to the mammal an effective amount of a non-antimicrobial tetracycline sufficient to inhibit excess phospholipase A.sub.2 activity and/or production is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.